Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06395090
Status:
RECRUITING
Last Update Posted:
2024-06-14
First Post:
2024-04-29
Brief Title:
A Study of Pembrolizumab in Combination With Investigational Agents in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors MK-9999-01BLIGHTBEAM-U01
Sponsor:
Organization:
Merck Sharp Dohme LLC